Literature DB >> 10577934

DNA sequence variants of p53: cancer and aging.

Y Sun, C Keshava, D S Sharp, A Weston, E C McCanlies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10577934      PMCID： PMC1288390          DOI： 10.1086/302650

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  35 in total

1.  True extended haplotypes of p53: indicators of breast cancer risk.

Authors:  A Weston; M S Wolff; A Morabia
Journal:  Cancer Genet Cytogenet       Date:  1998-04-15

2.  p53 haplotype determination in breast cancer.

Authors:  A Weston; C F Pan; H B Ksieski; S Wallenstein; G S Berkowitz; P I Tartter; I J Bleiweiss; S T Brower; R T Senie; M S Wolff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-02       Impact factor: 4.254

3.  Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

Authors:  A Storey; M Thomas; A Kalita; C Harwood; D Gardiol; F Mantovani; J Breuer; I M Leigh; G Matlashewski; L Banks
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

4.  Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.

Authors:  J To-Figueras; M Gene; J Gomez-Catalan; C Galan; J Firvida; M Fuentes; M Rodamilans; E Huguet; J Estape; J Corbella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-05       Impact factor: 4.254

5.  Interferon-alpha and p53 alleles involved in nasopharyngeal carcinoma.

Authors:  I Golovleva; R Birgander; A Själander; E Lundgren; L Beckman
Journal:  Carcinogenesis       Date:  1997-04       Impact factor: 4.944

6.  No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection.

Authors:  T Minaguchi; Y Kanamori; M Matsushima; H Yoshikawa; Y Taketani; Y Nakamura
Journal:  Cancer Res       Date:  1998-10-15       Impact factor: 12.701

7.  Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features.

Authors:  M Tagawa; M Murata; H Kimura
Journal:  Cancer Lett       Date:  1998-06-05       Impact factor: 8.679

8.  p53 codon 72 polymorphism and risk of cervical cancer in UK.

Authors:  A N Rosenthal; A Ryan; R M Al-Jehani; A Storey; C A Harwood; I J Jacobs
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  p53 germline polymorphisms are associated with an increased risk for breast cancer in German women.

Authors:  S Wang-Gohrke; T R Rebbeck; W Besenfelder; R Kreienberg; I B Runnebaum
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

10.  Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.

Authors:  A Weston; J H Godbold
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031
View more
  3 in total

1.  Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore.

Authors:  Woon-Puay Koh; David Van Den Berg; Aizhen Jin; Renwei Wang; Jian-Min Yuan; Mimi C Yu
Journal:  Breast Cancer Res Treat       Date:  2011-07-21       Impact factor: 4.872

2.  p53 polymorphisms in Russia and Belarus: correlation of the 2-1-1 haplotype frequency with longitude.

Authors:  A V Khrunin; L A Tarskaia; V A Spitsyn; O I Lylova; N A Bebyakova; A I Mikulich; S A Limborska
Journal:  Mol Genet Genomics       Date:  2005-01-15       Impact factor: 3.291

3.  p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan.

Authors:  L-L Hsieh; T-H Huang; I-H Chen; C-T Liao; H-M Wang; C-H Lai; S-H Liou; J T-C Chang; A-J Cheng
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.